Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Feasibility of repairing skin defects by VEGF 165 gene-modified iPS-HFSCs seeded on a 3D printed scaffold containing astragalus polysaccharide

Du W., Hu J., Huang X., Wang Z., Zhou H., Yang Y.

Animal Study on Face & Skin, Hair & Scalp, published in J Cell Mol Med (2023) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Cell Mol Med (2023)
Reported sample size
—
Source database
Europe PMC
PMID
37264501
PMCID
PMC10399531
DOI
10.1111/jcmm.17800
Citations
12

Abstract (original English)

The preparation of biodegradable scaffolds loaded with cells and cytokine is a feature of tissue-engineered skin. IPSCs-based tissue-engineered skin treatment for wound repair is worth exploring. Healthy human skin fibroblasts were collected and reprogrammed into iPSCs. After gene modification and induction, CK19 + /Integrinβ1 + /CD200 + VEGF 165 gene-modified iPS-HFSCs GFP were obtained and identified by a combination of immunofluorescence and RT-qPCR. Astragalus polysaccharide-containing 3D printed degradable scaffolds were prepared and co-cultured with VEGF 165 gene-modified iPS-HFSCs GFP , and the biocompatibility and spatial structure of the tissue-engineered skin was analysed by cell counting kit-8 (CCK8) assay and scanning electron microscopy. Finally, the tissue-engineered skin was transplanted onto the dorsal trauma of nude mice, and the effect of tissue-engineered skin on the regenerative repair of total skin defects was evaluated by a combination of histology, immunohistochemistry, immunofluorescence, RT-qPCR, and in vivo three-dimensional reconstruction under two-photon microscopy. CK19 + /Integrinβ1 + /CD200 + VEGF 165 gene-modified iPS-HFSCs GFP , close to the morphology and phenotype of human-derived hair follicle stem cells, were obtained. The surface of the prepared 3D printed degradable scaffold containing 200 μg/mL astragalus polysaccharide was enriched with

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansMiceMice, NudeCollagenPolysaccharidesVascular Endothelial Growth Factor ASkin TransplantationTissue EngineeringFeasibility Studies

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research